FENTON PHARMACEUTICALS LTDActive
Key figures
Like most small UK companies, FENTON PHARMACEUTICALS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 251,711 | 2,522,902 | 1,739,678 | 1,903,719 | 2,570,533 |
| Total assets | 3,719,723 | 6,698,738 | 6,785,974 | 8,512,736 | 12,872,400 |
| Total liabilities | — | 2,106,827 | 1,311,417 | 2,049,924 | 5,813,999 |
| Net assets / total equity | 3,471,795 | 4,591,911 | 5,474,557 | 6,462,812 | 7,058,401 |
| Average number of employees | 5 | 5 | 5 | 5 | 5 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Principal activity of the company during the financial year was of supply of Medical Equipment.
As described in the company's latest filed accounts.
Summary: FENTON PHARMACEUTICALS LTD
Company
FENTON PHARMACEUTICALS LTD is a private limited company registered with Companies House under company number 02808198. It was incorporated on 8 Apr 1993. Its status is active. The registered office is in London (NW3). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £7,058,401, up 9.2% on the previous year. Cash at bank and in hand was £2,570,533. Total assets were £12,872,400 and total liabilities £5,813,999. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
The company has 2 current directors. 2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 9 Jul 2027.